Results 171 to 180 of about 200,853 (296)

Molecular characterization of the A52 murine hepatocellular carcinoma cell line

Animal Models and Experimental Medicine, EarlyView.
Hepatocellular carcinoma (HCC) is a poor outcome cancer with limited therapeutic choices. To advance therapeutic development we genetically characterized the A52 murine HCC cell line. We noted genetic changes that match a subset of human HCC and this offers the opportunity to test novel targeted therapies in syngeneic mice.
Rhys Gillman, Eun Jin Sun, Miriam Wankell, Matt A. Field, Ulf Schmitz, Lionel Hebbard   +5 more
wiley   +1 more source

[Hepatocyte growth factor (HGF)].

Nihon rinsho. Japanese journal of clinical medicine, 1996
K, Sugimoto, K, Matsumoto, T, Nakamura
openaire   +4 more sources

Topical Hepatocyte Growth Factor Accelerates Wound Healing and Inhibits Scarring in Experimental Corneal Injury. [PDF]

Cornea
Elbasiony E, Mittal SK, Pulimamidi VK, Luan T, Orr S, Dana R, Chauhan SK.   +6 more
europepmc   +1 more source

Immunohistochemical expression of the hepatocyte growth factor in chromophobe renal cell carcinoma. [PDF]

BMC Urol, 2023
Erlmeier M, Mikuteit M, Zschäbitz S, Autenrieth M, Weichert W, Hartmann A, Steffens S, Erlmeier F.   +7 more
europepmc   +1 more source

Nonviral Gold Nanoparticle‐Mediated Delivery of CRISPR‐Cas9 Ribonucleoprotein and Long DNA Transgenes Into Primary Blood Cells

Advanced NanoBiomed Research, EarlyView.
CRISPR/Cas9 has revolutionized the field of gene therapy, but delivery remains an outstanding issue. We propose a nonviral gold‐nanoparticle platform for co‐delivery of CRISPR/Cas9 ribonucleoprotein and long 2.1 kilobase dsDNA transgene constructs. This CRISPR‐AuNP is inexpensive to produce and mediate gene editing and DNA delivery in T cells and CD34+
Rachel A. Cunningham, Karthikeya S. V. Gottimukkala, Daniel D. Lane, Katrina Poljakov, Patricia Lipson, Mark R. Enstrom, Alessandro Rizzi, Aude G. Chapuis, Jennifer E. Adair   +8 more
wiley   +1 more source

Association of Hepatocyte Growth Factor and Angiopoietin-2 with Systemic Cardiovascular Risk in Patients with Peripheral Artery Disease. [PDF]

J Clin Med
Li B, Khalil AM, Abuhalimeh L, Shaikh F, Younes H, Abuhalimeh B, Zamzam A, Abdin R, Qadura M.   +8 more
europepmc   +1 more source

Hepatocyte growth factor combined with adenosine deaminase as biomarker for diagnosis of tuberculous pleural effusion. [PDF]

Front Microbiol, 2023
Zheng SC, Huang ZY, Zhai K, Shi HZ, Shao MM.   +4 more
europepmc   +1 more source

Comparison of Receptor‐Mediated Endocytosis and Its Application to Enhance DNA Transfection by TFAMoplex

Advanced NanoBiomed Research, EarlyView.
We developed an assay to distinguish cellular binding from internalization. Compatible with microscopy and high‐throughput screening, the method identifies ligand‐mediated uptake. Applying top candidates to a protein‐based DNA carrier enhanced transfection efficiency, providing a rational strategy to improve non‐viral gene delivery systems.
David Scherer, Steffen Honrath, Jonas Kurmann, Alexander Klipp, Finn Brigger, Jean‐Christophe Leroux   +5 more
wiley   +1 more source

MHC-mismatched synovial mesenchymal stem cell injections delay knee osteoarthritis progression through hepatocyte growth factor secretion in rats. [PDF]

PLoS One
Kitahashi T, Nakamura K, Kogawa R, Sekiya I.   +3 more
europepmc   +1 more source

Effects of hepatocyte growth factor on porcine mammary cell growth and senescence. [PDF]

Biomedicine (Taipei), 2023
Huang CP, Liu LC, Lu HL, Shyr CR.
europepmc   +1 more source